Čes. slov. farm. 2021, 70(6):210-219 | DOI: 10.5817/CSF2021-6-210
Preformulation design of PLGA particulate system for multi-day drug delivery of the antidepressant mirtazapine
- 1 Masaryk University, Faculty of Pharmacy, Department of Pharmaceutical Technology, Brno, Czech Republic
- 2 Tescan Orsay, Brno, Czech Republic
- 3 Veterinary Research Institute, Department of Pharmacology and Toxicology, Brno, Czech Republic
In this experimental study, the biodegradable polylactide-co-glycolide (PLGA) microparticles (MP) loaded with the insoluble antidepressant mirtazapine were prepared by the simple o/w solvent evaporation method. The formation involved intrinsic variables, such as the content of polymer (700, 900 or 1200 mg), dichloromethane (5 or 10 ml) and/or drug (200 or 400 or 600 mg), and the volume of the aqueous emulsion phase (400, 600 or 800 ml). The influence of these parameters on the size and morphology of microparticles, encapsulation efficiency, and drug release behavior was observed. All MP were successfully prepared, and their size ranged between 165.34 ± 42.88 and 360.17 ± 121.59 μm. MP exhibited prolonged drug release (days), and some profiles had multiphasic character. It was found that the samples prepared with a higher initial amount of PLGA were bigger with prolonged lag time up to 34.3 hours. On the other hand, higher drug concentrations reduced the lag time. The external phase volume reduction and multiplication of dichloromethane amount prolonged the mirtazapine release and decreased the encapsulation efficiency. These observations were further confirmed by multivariate data analysis.
Keywords: microparticles; mirtazapine; PLGA; solvent evaporation method; multivariate data analysis
Grants and funding:
This research was supported by Masaryk University (Project MUNI/A/1574/2020) and the Ministry of Education, Youth and Sports of the Czech Republic (Project CZ.02.1.01/0.0/0.0/15_003/0000495).
Received: July 16, 2021; Accepted: December 3, 2021; Published: June 1, 2021 Show citation
ACS | AIP | APA | ASA | Harvard | Chicago | Chicago Notes | IEEE | ISO690 | MLA | NLM | Turabian | Vancouver |
References
- Okubo M., Murayama N., Miura J., Chiba Y., Yamazaki H. Effects of cytochrome P450 2D6 and 3A5 genotypes and possible coadministered medicines on the metabolic clearance of antidepressant mirtazapine in Japanese patients. Biochem. Pharmacol. 2015; 93, 104-109.
Go to original source...
Go to PubMed...
- Anttila S. A., Leinonen E. V. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev. 2001; 7, 249-264.
Go to original source...
Go to PubMed...
- Kasper S., Praschak-Rieder N., Tauscher J., Wolf R. A risk-benefit assessment of mirtazapine in the treatment of depression. Drug Saf. 1997; 17, 251-264.
Go to original source...
Go to PubMed...
- Verster J. C., van de Loo A. J. A. E., Roth T. Mirtazapine as positive control drug in studies examining the effects of antidepressants on driving ability. Eur. J. Pharmacol. 2015; 753, 252-256.
Go to original source...
Go to PubMed...
- Timmer C. J., Sitsen J. M., Delbressine L. P. Clinical pharmacokinetics of mirtazapine. Clin. Pharmacokinet. 2000; 38, 461-474.
Go to original source...
Go to PubMed...
- Ranjan O. P., Shavi G. V., Nayak U. Y., Arumugam K., Averineni R. K., Meka S. R., Sureshwar P. Controlled release chitosan microspheres of mirtazapine: In vitro and in vivo evaluation. Arch. Pharm. Res. 2011; 34, 1919-1929.
Go to original source...
Go to PubMed...
- Sah H., Thoma L. A., Desu H. R., Sah E., Wood G. C. Concepts and practices used to develop functional PLGA-based nanoparticulate systems. Int. J. Nanomed. 2013; 8, 747-765.
Go to original source...
Go to PubMed...
- Li M., Rouaud O., Poncelet D. Microencapsulation by solvent evaporation: state of the art for process engineering approaches. Int. J.Pharm. 2008; 3, 26-39.
Go to original source...
Go to PubMed...
- Vysloužil J., Doležel P., Kejdušová M., Košťál V., Beneš L., Dvořáčková K. Long-term controlled release of PLGA microparticles containing antidepressant mirtazapine. Pharm. Dev. Tech. 2016; 21, 214-221.
Go to original source...
Go to PubMed...
- Paskaris G., Bouropoulos N. Swelling studies and in vitro release of verapamil from calcium alginate and calcium alginate-chitosan beads. Int. J. Pharm. 2006; 323, 34-42.
Go to original source...
Go to PubMed...
- Wang S. B., Chen A. Z., Weng L. J., Chen M. Y., Xie X. L. Effect of drug-loading methods on drug load, encapsulation efficiency and release properties of alginate/poly-L arginine/chitosan ternary complex microcapsules. Macromol. Biosc. 2004; 4, 27-30.
Go to original source...
Go to PubMed...
- Song M., Li N., Sun S., Tiedt L. R., Liebenberg W., de Villiers M. M. Effect of viscosity and concentration of wall former, emulsifier and pore-inducer on the properties of amoxicillin microcapsules prepared by emulsion solvent evaporation. Il. Farmaco 2005; 60, 261-267.
Go to original source...
Go to PubMed...
- Sarkar A., Rohani S. Molecular salts and co-crystals of mirtazapine with promising physicochemical properties J. Pharm. Biomed. Anal. 2015; 110, 93-99.
Go to original source...
Go to PubMed...
- Costa P., Lobo J. M. S. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 2001; 13, 123-133.
Go to original source...
Go to PubMed...
- Samani M. S., Montaseri H., Kazemi A. The effect of polymer blends on release profiles of diclofenac sodium from matrices. Eur. J. Pharm. Biopharm. 2003; 55, 351-355.
Go to original source...
Go to PubMed...
- Ocaña J., Frutos G., Sánchez O. P. Using the similarity factor f2 in practice: A critical revision and suggestions for its standard error estimation. Chemom. Intell. Lab. Syst. 2009; 99, 49-56.
Go to original source...
- Vetchý D., Kopecká M., Vetchá M., Franc A. Modely in vitro - in vivo ve vývoji léčiv. Chem. Listy 2014; 108, 32-39.
- Feczkó T., Tóth J., Dósa G., Gyenis J. Influence of process conditions on the mean size of PLGA nanoparticles. Chem. Eng. Process. 2011; 50, 846-853.
Go to original source...
- Yang Y. Y., Chung T. S., Ng N. P. Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/evaporation method. Biomaterials 2001; 22, 231-241.
Go to original source...
Go to PubMed...
- Heslinga M. J., Mastria E. M., Eniola-Adefeso O. Fabrication of biodegradable spheroidal microparticles for drug delivery applications. J. Control. Rel. 2009; 138, 235-242.
Go to original source...
Go to PubMed...
- Mao S., Shi Y., Li L., Xu J., Schaper A., Kissel T. Effects of Process and Formulation Parameters on Characteristics and Internal Morphology of Poly(D, L-lactide-co-glycolide) Microspheres Formed by the Solvent Evaporation Method. Eur. J. Pharm. Biopharm. 2008; 68, 214-223.
Go to original source...
Go to PubMed...
- Choi H. S., Seo S-A., Khang G., Rhee J. M., Lee H. B. Preparation and characterization of fentanyl-loaded PLGA microspheres: in vitro release profiles. Int. J. Pharm. 2002; 234, 195-203.
Go to original source...
Go to PubMed...
- Yeo Y., Park K. control of encapsulation efficiency and initial burst in polymeric microparticle systems. Arch. Pharm. Res. 2004; 27, 1-12.
Go to original source...
Go to PubMed...
- Doan T. V. P., Couet W., Olivier J. C. Formulation and in vitro characterization of inhalable rifampicin-loaded PLGA microspheres for sustained lung delivery. Int. J. Pharm. 2011; 414, 112-117.
Go to original source...
Go to PubMed...
- André-Abrant A., Taverdet J. L., Jay J. microencapsulation par évaporation de solvant. Eur. Polym. J. 2001; 37, 955-967.
Go to original source...
- Klose D., Siepmann F., Elkharraz K., Krenzlin S., Siepmann J. How porosity and size affect the drug release mechanisms from PLGA-based microparticles. Int. J. Pharm. 2006; 314, 198-206.
Go to original source...
Go to PubMed...
- Yang Y. Y., Chung T. S., Bai X. L., Chan W. K. Effect of preparation conditions on morphology and release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion method. Chem. Eng. Sci. 2000; 55, 2223-2236.
Go to original source...
- O'Donnell P. B., McGinity J. W., Zhu K. J., Liu J. H., Hao Y. L. Influence of processing on the stability and release properties of biodegradable microspheres containing thioridazine hydrochloride. Eur. J. Pharm. Biopharm. 1998; 45, 83-94.
Go to original source...
Go to PubMed...
- Fredenberg S., Wahlgren M., Reslow M., Axelsson A. The mechanisms of drug release in poly(lactic-co-glycolic acid)-based drug delivery systems - a review. Int. J. Pharm. 2011; 415, 34-52.
Go to original source...
Go to PubMed...
- Reimann C., Filzmoser P., Garret R. G., Dutter R. Statistical data analysis explained: applied environmental statistics with R. Chichester: John Wiley & Sons 2008.
Go to original source...